Publication: Secukinumab is effective in the treatment of recalcitrant palmoplantar psoriasis and palmoplantar pustular psoriasis in a daily practice setting.
No Thumbnail Available
Identifiers
Date
2022-05-28
Authors
Reolid, Alejandra
Armesto, Susana
Sahuquillo-Torralba, Antonio
Torres, Tiago
Feltes, Rosa
Vilarrasa, Eva
Belinchón, Isabel
Cueva, Pablo de la
Rodríguez, Lourdes
Romero-Maté, Alberto
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Metrics
Export
Abstract
Description
MeSH Terms
Antibodies, Monoclonal, Humanized
Humans
Psoriasis
Humans
Psoriasis
DeCS Terms
CIE Terms
Keywords
daily practice setting, palmoplantar psoriasis, palmoplantar pustular psoriasis, secukinumab